AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Shappell, SB Manning, S Boeglin, WE Guan, YF Roberts, RL Davis, L Olson, SJ Jack, GS Coffey, CS Wheeler, TM Breyer, MD Brash, AR
Citation: Sb. Shappell et al., Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma, NEOPLASIA, 3(4), 2001, pp. 287-303

Authors: Grossklaus, DJ Coffey, CS Shappell, SB Jack, GS Cookson, MS
Citation: Dj. Grossklaus et al., Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores, BJU INT, 88(7), 2001, pp. 722-726

Authors: Dutta, SC Smith, JA Shappell, SB Coffey, CS Chang, SS Cookson, MS
Citation: Sc. Dutta et al., Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy, J UROL, 166(2), 2001, pp. 490-493

Authors: Grossklaus, DJ Shappell, SB Adams, MC Brock, JW Pope, JC
Citation: Dj. Grossklaus et al., Small intestinal submucosa as a urethral coverage layer, J UROL, 166(2), 2001, pp. 636-639

Authors: Grossklaus, DJ Shappell, SB Gautam, S Smith, JA Cookson, MS
Citation: Dj. Grossklaus et al., Ratio of free-to-total prostate specific antigen correlates with tumor volume in patients with increased prostate specific antigen, J UROL, 165(2), 2001, pp. 455-458

Authors: Shappell, SB Keeney, DS Zhang, J Page, R Olson, SJ Brash, AR
Citation: Sb. Shappell et al., 15-lipoxygenase-2 expression in benign and neoplastic sebaceous glands andother cutaneous adnexa, J INVES DER, 117(1), 2001, pp. 36-43

Authors: Masumori, N Thomas, TZ Chaurand, P Case, T Paul, M Kasper, S Caprioli, RM Tsukamoto, T Shappell, SB Matusik, RJ
Citation: N. Masumori et al., A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential, CANCER RES, 61(5), 2001, pp. 2239-2249

Authors: Shappell, SB Gupta, RA Manning, S Whitehead, R Boeglin, WE Schneider, C Case, T Price, J Jack, GS Wheeler, TM Matusik, RJ Brash, AR DuBois, RN
Citation: Sb. Shappell et al., 15S-hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells, CANCER RES, 61(2), 2001, pp. 497-503

Authors: Matusik, RJ Masumori, N Thomas, T Case, T Paul, M Kasper, S Shappell, SB
Citation: Rj. Matusik et al., Transgenic mouse models of prostate cancer, CONT ENDOC, 2001, pp. 401-425

Authors: Jack, GS Brash, AR Olson, SJ Manning, S Coffey, CS Smith, JA Shappell, SB
Citation: Gs. Jack et al., Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: Correlation with grade and expression in high-grade prostatic intraepithelial neoplasia, HUMAN PATH, 31(9), 2000, pp. 1146-1154

Authors: Shappell, SB Mendoza, LH Gurpinar, T Smith, CW Suki, WN Truong, LD
Citation: Sb. Shappell et al., Expression of adhesion molecules in kidney with experimental chronic obstructive uropathy: The pathogenic role of ICAM-1 and VCAM-1, NEPHRON, 85(2), 2000, pp. 156-166

Authors: Komhoff, M Guan, YF Shappell, HW Davis, L Jack, G Shyr, Y Koch, MO Shappell, SB Breyer, MD
Citation: M. Komhoff et al., Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas, AM J PATH, 157(1), 2000, pp. 29-35

Authors: Shappell, SB Boeglin, WE Olson, SJ Kasper, S Brash, AR
Citation: Sb. Shappell et al., 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma, AM J PATH, 155(1), 1999, pp. 235-245
Risultati: 1-13 |